title: Development of REM sleep drive and clinical implications.
abstract: Rapid eye movement (REM) sleep in the human declines from approximately 50% of total sleep time ( approximately 8 h) in the newborn to approximately 15% of total sleep time (approximately 1 h) in the adult, and this decrease takes place mainly between birth and the end of puberty. We hypothesize that without this developmental decrease in REM sleep drive, lifelong increases in REM sleep drive may ensue. In the rat, the developmental decrease in REM sleep occurs 10-30 days after birth, declining from >70% of total sleep time in the newborn to the adult level of approximately 15% of sleep time during this period. Rats at 12-21 days of age were anesthetized with ketamine and decapitated, and brain stem slices were cut for intracellular recordings. We found that excitatory responses of pedunculopontine nucleus (PPN) neurons to N-methyl-D-aspartic acid decrease, while responses to kainic acid increase, over this critical period. During this developmental period, inhibitory responses to serotonergic type 1 agonists increase but responses to serotonergic type 2 agonists do not change. The results suggest that as PPN neurons develop, they are increasingly activated by kainic acid and increasingly inhibited by serotonergic type 1 receptors. These processes may be related to the developmental decrease in REM sleep. Developmental disturbances in each of these systems could induce differential increases in REM sleep drive, accounting for the postpubertal onset of a number of different disorders manifesting increases in REM sleep drive. Examination of modulation by PPN projections to ascending and descending targets revealed the presence of common signals modulating ascending arousal-related functions and descending postural/locomotor-related functions.
authors.affiliation: Center for Translational Neuroscience, Department of Anatomy and Neurobiology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: C
authors.initials: C
authors.lastname: Good
authors.forename: K
authors.initials: K
authors.lastname: Mamiya
authors.forename: R D
authors.initials: RD
authors.lastname: Skinner
authors.forename: E
authors.initials: E
authors.lastname: Garcia-Rill
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001143:Arousal / Q000502:physiology; D004558:Electric Stimulation; D005260:Female; D066298:In Vitro Techniques; D009068:Movement / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D045042:Pedunculopontine Tegmental Nucleus / Q000166:cytology / Q000502:physiology*; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D018092:Kainic Acid Receptors / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D011985:Receptors, Serotonin / Q000502:physiology; D012895:Sleep, REM / Q000502:physiology*
chemical_list: D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; D011985:Receptors, Serotonin